Compounds > ulipristal acetate
Page last updated: 2024-09-03

ulipristal acetate and Disease Exacerbation

ulipristal acetate has been researched along with Disease Exacerbation in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Donnez, J; Donnez, O1
Agostini, A; Calderon, L; Grob-Vaillant, A; Mancini, J; Netter, A; Siles, P; Vidal, V1
Camilli, S; Conway, F; Exacoustos, C; Martire, FG; Morosetti, G; Piccione, E; Sorrenti, G; Zupi, E1
Istre, O1

Other Studies

4 other study(ies) available for ulipristal acetate and Disease Exacerbation

ArticleYear
Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis.
    Fertility and sterility, 2020, Volume: 114, Issue:3

    Topics: Adenomyosis; Adult; Disease Progression; Drug Substitution; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Norpregnadienes; Remission Induction; Severity of Illness Index; Treatment Failure; Uterus

2020
Progression of adenomyosis magnetic resonance imaging features under ulipristal acetate for symptomatic fibroids.
    Reproductive biomedicine online, 2021, Volume: 42, Issue:3

    Topics: Adenomyosis; Adult; Contraceptive Agents, Female; Disease Progression; Female; Humans; Leiomyoma; Magnetic Resonance Imaging; Norpregnadienes; Pilot Projects; Prospective Studies

2021
Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2019, Volume: 35, Issue:3

    Topics: Adenomyosis; Diagnostic Errors; Disease Progression; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Ultrasonography; Uterine Neoplasms; Uterus

2019
Unexpected Uterine Leiomyosarcoma During Laparoscopic Hysterectomy Treated 6 Months With Ulipristal Acetate and Contained Power Morcellation.
    Journal of minimally invasive gynecology, 2017, Volume: 24, Issue:2

    Topics: Delayed Diagnosis; Denmark; Disease Progression; Female; Humans; Hysterectomy; Intraoperative Period; Laparoscopy; Leiomyoma; Leiomyosarcoma; Lung Neoplasms; Menorrhagia; Middle Aged; Minimally Invasive Surgical Procedures; Morcellation; Norpregnadienes; Uterine Neoplasms

2017